Companies›Paziresh24

Paziresh24

HealthtechtelemedicineIndependentIndex constituent
Entity IDIR-CO-2132
SectorHealthtech
Founded2015
HQTehran
VerificationReported

Digital health platform: online doctor appointments / telemedicine / super-app

Tehran Index tracks this company as part of a source-linked research record on Iran’s technology economy. Access opens to a limited first cohort. Register for access, or browse the registry.

Operating metrics, period-stamped
Appointments bookedMarch to September 2021Company disclosed
3,900,000+ appointments, up 29% on the preceding six months. 12,000 doctors and 400 medical centres on the platform
Paziresh24 half-year report, rehosted by DMBoard ↗ · retrieved 2026-08-18Persian original: «در نیمه اول سال ١۴٠٠ بیش از ٣.٩ میلیون نوبت داده». STALENESS: five years old. Checked 2026-08-18 for a more recent company report; none found. Carried with its date rather than presented as current.
Source ledger, every field, its evidence
Appointments bookedCompany disclosedMarch to September 2021
3,900,000+ appointments, up 29% on the preceding six months. 12,000 doctors and 400 medical centres on the platform
Paziresh24 half-year report, rehosted by DMBoard ↗ · retrieved 2026-08-18retrieved 2026-08-18
Work with this record
All Paziresh24 signalsEvidence Library

Alerts, company comparisons, and full-history exports are joining the partner workspace. Request access →

Registered entity
Legal entitySepehr Salamat Kavir Isatis
Entity typeoperating
StatusActive
Evidence & verification
Verification tierReported, single public source
Primary evidencewww.paziresh24.com
Registry identifiersWithheld for compliance

Fields on this profile derive from linked public sources or the official company registry; unknown values stay blank rather than guessed, and estimates are always labelled. How we verify →

Quick facts
Tehran, Iran
Founded 2015
www.paziresh24.comLinkedIn
Institutional access

This dossier shows the working standard. Institutional access will add a scoped custom dossier or watchlist, the weekly briefing, sourced research requests, coverage reviews, and dataset exports. It is not open yet; the first cohort is being registered now.

Request Access